Tumor mutational burden presents limiting effects on predicting the efficacy of immune checkpoint inhibitors and prognostic assessment in adrenocortical carcinoma

Xu, FS; Guan, YB; Zhang, P; Xue, L; Ma, YB; Gao, M; Chong, T; Ren, BC

Ren, BC (通讯作者),Xi An Jiao Tong Univ, Dept Rheumatol & Immunol, Affiliated Hosp 2, 157 West Five Rd, Xian 710000, Shaanxi, Peoples R China.

BMC ENDOCRINE DISORDERS, 2022; 22 (1):

Abstract

Background Adrenocortical carcinoma (ACC) is a highly malignant urologic cancer and tends to metastasize. Although immune checkpoint inhibitors (ICIs)......

Full Text Link